Why the study?
Is global end-diastolic volume (GEDV) a reliable preload marker compared to traditional pulmonary artery catheter-derived parameters in patients with severe circulatory dysfunction?
Is global end-diastolic volume (GEDV) a reliable preload marker compared to traditional pulmonary artery catheter-derived parameters in patients with severe circulatory dysfunction?
GEDV measured by minimally invasive transpulmonary thermodilution systems is a promising and reliable bedside marker for cardiac preload in severe circulatory dysfunction.
Supports GEDV as preload marker in circulatory dysfunction; leaves open need for prospective validation before adoption.
A reliable estimation of cardiac preload is helpful in the management of severe circulatory dysfunction. The estimation of cardiac preload has evolved from nuclear angiography, pulmonary artery catheterization to echocardiography, and transpulmonary thermodilution (TPTD). Global end-diastolic volume (GEDV) is the combined end-diastolic volumes of all the four cardiac chambers. GEDV has been demonstrated to be a reliable preload marker in comparison with traditionally used pulmonary artery catheter-derived pressure preload parameters. Recently, a new TPTD system called EV1000™ has been developed and introduced into the expanding field of advanced hemodynamic monitoring. GEDV has emerged as a better preload marker than its previous conventional counterparts. The advantage of it being measured by minimum invasive methods such as PiCCO™ and newly developed EV1000™ system makes it a promising bedside advanced hemodynamic parameter.
No takes yet. Share an insight, caveat, or question.
Kapoor et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: